T.S. Martins , B.F.C. Correia , D.S.C.P. Grosa , R.M.S. Salvador , I. Brites , C.X. de Sousa , I.M.R. Matos Pina , S. Braga , A. Jacinto , G. Cabral
{"title":"30P The prognostic value of low density neutrophils in breast cancer: Implications for therapeutic strategies","authors":"T.S. Martins , B.F.C. Correia , D.S.C.P. Grosa , R.M.S. Salvador , I. Brites , C.X. de Sousa , I.M.R. Matos Pina , S. Braga , A. Jacinto , G. Cabral","doi":"10.1016/j.iotech.2024.100912","DOIUrl":"10.1016/j.iotech.2024.100912","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100912"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.R. Filippi , M. R. García Campelo , J-B. Paoli , D. Kowalski , C. Bennati , P. Borghetti , D. Cortinovis , A. Delmonte , C. Genova , R. Mroz , S. Nawrocki , I. Toledano , G. Tonini , F. Agustoni , G. Wetherill , I. Diaz Perez , N. Georgoulia , R. Dziadziuszko
{"title":"66MO Durvalumab after radiotherapy (RT) in patients (pts) with unresectable stage III NSCLC ineligible for chemotherapy (CT): Final analysis of the phase II DUART study","authors":"A.R. Filippi , M. R. García Campelo , J-B. Paoli , D. Kowalski , C. Bennati , P. Borghetti , D. Cortinovis , A. Delmonte , C. Genova , R. Mroz , S. Nawrocki , I. Toledano , G. Tonini , F. Agustoni , G. Wetherill , I. Diaz Perez , N. Georgoulia , R. Dziadziuszko","doi":"10.1016/j.iotech.2024.100809","DOIUrl":"10.1016/j.iotech.2024.100809","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100809"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143175999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Persano , L. Fornaro , L. Antonuzzo , T. Satake , H. Vandeputte , J. Lucchetti , J.W. Kim , O. Abidoye , I.G. Rapposelli , S. Tamberi , F. Finkelmeier , G. Giordano , F. Nicchetti , H.J. Chon , C. Yoo , S.L. Chan , M. Scartozzi , S. Lonardi , L. Rimassa , A. Casadei Gardini
{"title":"77P A new prognostic index for patients with advanced BTC treated with cisplatin, gemcitabine and durvalumab","authors":"M. Persano , L. Fornaro , L. Antonuzzo , T. Satake , H. Vandeputte , J. Lucchetti , J.W. Kim , O. Abidoye , I.G. Rapposelli , S. Tamberi , F. Finkelmeier , G. Giordano , F. Nicchetti , H.J. Chon , C. Yoo , S.L. Chan , M. Scartozzi , S. Lonardi , L. Rimassa , A. Casadei Gardini","doi":"10.1016/j.iotech.2024.100820","DOIUrl":"10.1016/j.iotech.2024.100820","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100820"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Ramaswamy , V. Shenoy , A. Bahl , A. Kapoor , V. Talwar , V. Muddu , A. Rauthan , R. Pinninti , A.M. Khan , S.J. Rajappa , N. Rohatgi , M. Sharma , P.G. Bhargava , A. Gupta , B. Sansar , U. Batra , V.S. Ostwal
J.M. Berger , E. Tomasich , V. Sunder-Plassmann , M. Kleinberger , P. Hettegger , L. Gottmann , I. Solano Henao , M. Korpan , U. Setinek , A. Valipour , M.J. Hochmair , L. Beer , H. Prosch , R. Kain , J. Furtner , G. Heller , M. Preusser , A.S. Berghoff
T. Lim , K. Montazeri , A. Desilets , A.N. Shoushtari , R. Seedor , M. Orloff , T. Sato , M. Caplan , M. El-Ashmawy , B. Izar , S. Khan , R.D. Carvajal , I. Mehmi , O. Hamid , R. Sullivan
A. Soria Rivas , M.A. Berciano Guerrero , E. Muñoz-Couselo , P.C. Cerezuela-Fuentes , C. Aguado , P. Ayala de Miguel , G. Crespo Herrero , L. Gutierrez Sanz , L. Ostios Garcia , D. Vilanova Larena , S. Martin Algarra , I. Marquez-Rodas
{"title":"68P Real-world outcomes of nivolumab and/or ipilimumab in patients with stage III-IV melanoma, MELIOR study","authors":"A. Soria Rivas , M.A. Berciano Guerrero , E. Muñoz-Couselo , P.C. Cerezuela-Fuentes , C. Aguado , P. Ayala de Miguel , G. Crespo Herrero , L. Gutierrez Sanz , L. Ostios Garcia , D. Vilanova Larena , S. Martin Algarra , I. Marquez-Rodas","doi":"10.1016/j.iotech.2024.100811","DOIUrl":"10.1016/j.iotech.2024.100811","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100811"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
